Successful commercialization of a new biotechnology not only benefits patients and customers, but also creates enormous value for researchers/inventors, universities/research institutions, technology transfer companies, emerging and established companies, local and regional economies and financial investors. Achieving proof of principle, developing prototype then advanced products, securing licensees and partners, and launching a product successively add value - in the case of a drug, $100m or more. How much of the value chain are you currently creating and capturing? How much could you create and capture (see Capturing Value)? A successful local exploitation of the technology could create numerous well-paid jobs and strong innovation capabilities for future leverage. Financial rewards may be recycled into university research. You may increase the probability of success - small, focused companies regularly beat larger companies in the innovation stakes. You may retain much more control over the exploitation of your technology. Biopons helps clients analyse these opportunities and craft strategies that maximize the benefits. And for selected opportunities we'll roll up our sleeves and work to implement the plan for the benefits of all stakeholders (see Portfolio Companies). BIOPONS specializes in tailoring solutions for a wide range of clients, including: Researchers/Inventors. Keen to see your technology exploited? Not sure how to do it? Want a say in its development, but want to retain your research position? Need independent objective technology and/or market analysis or to develop a strategy?
Universities/Research Institutions. Under increasing pressure to arrange commercial exploitation of your technologies? Frustrated by the development-stage gap between what you have and what licensees want? Eager to capture more value, but lacking the resources or capabilities to bridge the gap? Need to avoid distorting your primary purpose?
Technology Transfer Companies. You likely have the all expertise you need for outlicensing technologies - but might still find our specialised knowledge and network of contacts helpful. We'll work with you to review your portfolio and identify technologies from which greater value could be captured; for suitable opportunities, we will propose tailored solutions, which can include a shared approach to risk and reward.
Bioscience-Based Companies. Constant demand for strategic analysis to ensure your resources are optimally allocated, to ensure you will survive and prosper in an always competitive environment? Need to make objective decisions on opportunities? BIOPONS can relieve your stretched resources.
Economic Development Agencies. Cities and regions across the world are vying for a slice of the biotechnology pie. What assets in your locale can be leveraged to attract biotechnology investment? You need to be realistic, and creative. Rural economies, unlikely competitors for biotech dollors, have received an unexpected windfall from bio-ethanol.
Financial Investors. BIOPONS will assist you in evaluating investment propositions. |
